Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors
Beate Schultheis(Universitätsklinik Marien Hospital Herne), Gerhard Kummer(Ruhr University Bochum), Matthias Zeth(Ruhr University Bochum), E. Brendel(Bayer (United States)), Chenjing Xia(Bayer (United States)), Martin Kornacker(Bayer (United States)), Dirk Strumberg(Ruhr University Bochum)
Cited by 12
Abstract
Related Papers
No related papers found
Powered by citation graph analysis